The burgeoning popularity of tirzepatide , initially for metabolic conditions, is creating significant interest within the UK , prompting a notable shift in medication trends. Obtaining these treatments remains a complex challenge , with National Health Service approval currently limited and private clinics offering prescriptions at a higher cost .